Not applicableStudy completedNCT02148380What this trial is testingCombination of Chemotherapy and Gefitinib as First-line TreatmentWho this might be right forNon-Small-Cell Lung Cancer Baohui Han 121
Testing effectiveness (Phase 2)Study completedNCT00428142What this trial is testingBortezomib, Combination Chemotherapy, and Rituximab as First-Line Therapy in Treating Patients With Stage III or Stage IV Follicular Non-Hodgkin's LymphomaWho this might be right forLymphoma NCIC Clinical Trials Group 95
Testing effectiveness (Phase 2)Looking for participantsNCT07096362What this trial is testingUtility of ctDNA in Early Switch of First-line Chemotherapy in Metastatic Pancreatic Ductal AdenocarcinomaWho this might be right forMetastatic Pancreatic Ductal AdenocarcinomaPancreatic Ductal Adenocarcinoma University of Miami 50
Large-scale testing (Phase 3)Active Not RecruitingNCT04547504What this trial is testingPEmbRolizumab verSus chEmotherapy and pEmbrolizumab in Non-small-cell Lung Cancers (NSCLC) With PDL1 ≥ 50 %Who this might be right forNon-small-cell Lung Cancer University Hospital, Brest 349
Testing effectiveness (Phase 2)Study completedNCT00636610What this trial is testingVismodegib (GDC-0449, Hedgehog Pathway Inhibitor) With Concurrent Chemotherapy and Bevacizumab As First-Line Therapy for Metastatic Colorectal CancerWho this might be right forMetastatic Colorectal Cancer Genentech, Inc. 199
Post-approval studies (Phase 4)UnknownNCT04554524What this trial is testingChemotherapy Combined With Pembrolizumab in Treating Patients With Thymoma and Thymic CarcinomaWho this might be right forThymoma and Thymic Carcinoma Tang-Du Hospital 40
Large-scale testing (Phase 3)UnknownNCT02024438What this trial is testingMonosialotetrahexosylganglioside Sodium Injection for Prevention Neurotoxicity of mFOLFOX 6 in Advanced Gastric CancerWho this might be right forGastric Cancer Tianjin Medical University Cancer Institute and Hospital 240
Post-approval studies (Phase 4)Study completedNCT03321955What this trial is testingZiconotide as First-Line IDTWho this might be right forNeuropathic Pain Albany Medical College 13
Large-scale testing (Phase 3)UnknownNCT03402048What this trial is testingThe EPIC Trial The Elderly Patient Individualized Chemotherapy TrialWho this might be right forStage IV, NSCLCLung NeoplasmsBronchial Neoplasms+6 more University of Turin, Italy 567
Testing effectiveness (Phase 2)Study completedNCT04188847What this trial is testingFirst-line Chemotherapy for Recurrent Cervical CancerWho this might be right forRecurrent Cervical CarcinomaPersistent Advanced Cervical CarcinomaChemotherapy+3 more Lei Li 37
Testing effectiveness (Phase 2)Ended earlyNCT01120158What this trial is testingPaclitaxel Plus Bevacizumab for Older Patients With Breast CancerWho this might be right forBreast Cancer Hellenic Oncology Research Group 46
Large-scale testing (Phase 3)Study completedNCT04799249What this trial is testingTrilaciclib, a CDK 4/6 Inhibitor, in Patients Receiving Gemcitabine and Carboplatin for Metastatic Triple-Negative Breast Cancer (TNBC)Who this might be right forTNBC - Triple-Negative Breast CancerBreast Cancer G1 Therapeutics, Inc. 194
Large-scale testing (Phase 3)UnknownNCT03423849What this trial is testingThe Maintenance Regimen and Revised Regimen for Advanced Breast Cancer Survivors After First-line Salvage TherapyWho this might be right forBreast CancerChemotherapy EffectDisease-free Survival Zhiyong Yu 200
Testing effectiveness (Phase 2)WithdrawnNCT05966233What this trial is testingR-DHAP vs POLA-R-DHAP Followed by Autologous Transplant as First Salvage Treatment in Patient With Relapsed or Refractory Diffuse Large B Cell LymphomaWho this might be right forDiffuse Large B Cell Lymphoma RefractoryDiffuse Large B-cell Lymphoma Recurrent Fondazione Italiana Linfomi - ETS
Not applicableLooking for participantsNCT06827353What this trial is testingNiraparib Versus Bevacizumab as Maintenance Therapy in Patients With de Novo Ovarian Cancer Without Homologous Recombination DeficiencyWho this might be right forOvarian Carcinoma Centre Hospitalier Universitaire de Nīmes 300
Testing effectiveness (Phase 2)Study completedNCT03007992What this trial is testingMetronomic Treatment With Daily Oral Vinorelbine as First-line Chemotherapy in Patients With Advanced/Metastatic Hormone Receptor Positive (HR+)/Human Epidermal Growth Factor Receptor 2 Negative (HER2-) Breast CancerWho this might be right forMetastatic Breast Cancer Johannes Gutenberg University Mainz 9
Testing effectiveness (Phase 2)Study completedNCT02593175What this trial is testingWomen's MoonShot: Neoadjuvant Treatment With PaCT for Patients With Locally Advanced TNBCWho this might be right forStage I Breast Cancer AJCC v7Stage IA Breast Cancer AJCC v7Stage IB Breast Cancer AJCC v7+8 more M.D. Anderson Cancer Center 43
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07382713What this trial is testingFluzoparib Plus Famitinib Maintenance After First-Line Platinum Response in Advanced Ovarian CancerWho this might be right forOvarian Cancer Jinhua Zhou 43
Large-scale testing (Phase 3)WithdrawnNCT00403182What this trial is testingChemotherapy and Hormone Therapy as First-Line Therapy in Treating Postmenopausal Women With Metastatic or Locally Advanced Breast CancerWho this might be right forBreast Cancer Technical University of Munich
Testing effectiveness (Phase 2)Study completedNCT00504192What this trial is testingA Phase II Study of Gemcitabine With Oxaliplatin as First Line Chemotherapy in Advanced Biliary Tract CancerWho this might be right forAdvanced Biliary Tract AdenocarcinomaGemcitabineOxaliplatin+2 more Soonchunhyang University Hospital 40